By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mitsubishi Pharma Corporation (Merger Between Welfide Corporation And Mitsubishi-Tokyo Pharmaceuticals, Inc.) 

Mitsubishi Welpharma Kabushiki Kaisha (In Japan)
2-6-9, Hiranomachi
Chuo-ku  Osaka  541-0046  Japan
Phone: 81-6-6201-1600 Fax: +81-6-6233-2516


SEARCH JOBS



Segment
Drug Discovery

Collaborations

Vertex Pharmaceuticals (MA)  (telaprevir for HCV) - Japan and certain Far East countries





Company News
Mitsubishi Pharma Corporation JV Building $20 Million Plant in Tianjin 8/8/2013 12:35:16 PM
Genelabs Technologies, Inc. (GNLB) Regains Exclusive Rights to Prestara(TM) in Japan From Mitsubishi Pharma Corporation 11/19/2007 7:15:18 AM
Quark Pharmaceuticals Inc. (QURK) to Receive Development Milestone Payment From Mitsubishi Pharma Corporation 10/9/2007 8:37:59 AM
BioWisdom Announces Mitsubishi Pharma Corporation to use BioWisdom KnowledgeScan(TM) 6/5/2007 10:36:43 AM
Medarex, Inc. (MEDX) Announces Collaborative Research Agreement with Mitsubishi Pharma Corporation 5/31/2007 11:05:24 AM
BrainCells, Inc. In-Licenses Clinical-Stage CNS Compound From Mitsubishi Pharma Corporation 8/10/2006 11:44:25 AM
Mitsubishi Pharma Corporation To Establish Pharmaceutical Development Company In Beijing, New Jobs 5/15/2006 4:14:01 PM
BG Medicine To Conduct Joint Biomarker Discovery Study For Muscle Toxicity With Mitsubishi Pharma Corporation 3/28/2006 12:36:30 PM
Mitsubishi Pharma Corporation To License ZIONE Internal Hemorrhoid Drug To Yuhan Corporation 2/24/2006 11:35:52 AM
AVEO Pharmaceuticals, Inc. Acquires Rights To Novel Anti-Cancer Compound From Mitsubishi Pharma Corporation 1/5/2006 10:23:25 AM
1234
//-->